Tag: Biomarkers
Lunit takes pathology AI into drug research with US lab pact
Cancer pathology software from Lunit, a Korean medical AI company, is headed into pharmaceutical research. A partnership with Discovery Life…
CellCarta and Imagene AI target regulator-ready cancer diagnostics
CellCarta and Imagene AI are widening a companion-diagnostics collaboration that aims to move AI pathology from the research bench into…
Lung cancer AI outpredicts PD-L1 on who benefits from immunotherapy
A Nature Medicine study spanning six countries found AI models beat standard biomarkers at forecasting immunotherapy response in advanced lung…
AWS hands Columbia researchers cloud credits for diagnostic AI
Columbia University Irving Medical Center and AWS have launched a collaboration to build and commercialize AI-driven biomarkers and diagnostics.
Flatiron adds AI-extracted biomarkers to 345,000-patient lung dataset
Flatiron Health's lung cancer dataset gains AI-extracted biomarker detail across more than 345,000 patients.
Deep learning reads organ age from routine biopsy slides
Deep learning tissue clocks estimate biological age for 40 organs from routine biopsy slides.
COMPASS model predicts immunotherapy outcomes across 33 cancer types
The pan-cancer foundation model outperforms 22 other methods and generalizes to treatments not seen during training.
AI Platform Rescues Lost Research Data to Accelerate Medical Discovery
An AI powered data management platform converts lost research datasets into citable, reusable assets that can accelerate medical AI training…